1-4 of 4
Robert F. Manges
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Multicenter Study of Siltuximab, An Anti-IL-6 Monoclonal Antibody, in Patients with Relapsed or Refractory Multiple Myeloma,

Peter M. Voorhees, MD, Robert F Manges, MD, Pieter Sonneveld, MD, PhD, Sundar Jagannath, MD, George Somlo, MD, Amrita Krishnan, MD, Suzanne Lentzsch, MD, PhD, Richard C Frank, MD, Sonja Zweegman, MD, PhD, P.W. Wijermans, MD, PhD, Britte Rijnbeek, Xiang Qin, PhD, Mark J. Cornfeld, MD, MPH, Hong Xie, MD, MS, MBA, Sheeba K. Thomas, MD
Journal: Blood
Blood (2011) 118 (21): 3971.
https://doi.org/10.1182/blood.V118.21.3971.3971
Published: 2011
Journal Articles

Phase 3b UPFRONT Study: Interim Results From a Community Practice-Based Prospective Randomized Trial Evaluating Three Bortezomib-Based Regimens in Elderly, Newly Diagnosed Multiple Myeloma Patients.

Ruben Niesvizky, James Reeves, Ian W Flinn, Robert M. Rifkin, Billy Clowney, Nashat Gabrail, Vijay R. Phooshkooru, Veena Charu, Christopher H. Chay, Deyanira Corzo, Rachel Neuwirth, Robert F. Manges, Thomas A. Warr
Journal: Blood
Blood (2009) 114 (22): 129.
https://doi.org/10.1182/blood.V114.22.129.129
Published: 2009
Journal Articles

Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma

Jean-Francois Rossi, MD, PhD, Robert F. Manges, MD, Heather J. Sutherland, MD, PhD, Sundar Jagannath, MD, Peter Voorhees, MD, Pieter Sonneveld, MD, Michel Delforge, MD, PhD, Brigitte Pegourie, MD, Adrian Alegre, MD, Javier de la Rubia, MD, David La Police, BS, Rajesh Bandekar, PhD, Hong Xie, MD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 867.
https://doi.org/10.1182/blood.V112.11.867.867
Published: 2008
Journal Articles

Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.

Robert F. Manges, MD, Heather J. Sutherland, MD, Sundar Jagannath, MD, Robert Z. Orlowski, MD, PhD, David La Police, Mark DeWitte, VMD, Zhihui Lang, MD, PhD, Robert E. Corringham, MD, Jean Francois Rossi, MD
Journal: Blood
Blood (2007) 110 (11): 1183.
https://doi.org/10.1182/blood.V110.11.1183.1183
Published: 2007